An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone asked whether certain drugs or substances that cause euphoria (a strong feeling of wellbeing or pleasure) can count as nootropics — that is, as things that boost cognition, memory, or mental performance. The short news here is not a study result but a question: can a substance be both euphoric and genuinely “brain-enhancing,” either directly by changing brain chemistry in helpful ways, or indirectly by lifting mood so someone can think better? First, what do we mean by the word “peptide” and the other terms tossed in the question? Peptides are small chains of amino acids — basically tiny proteins. Some of them act in the brain to change how cells talk to one another. Semax and Selank are synthetic peptides developed in Russia; they are sold and discussed as cognitive enhancers in some communities. DLPA is an amino acid supplement that can boost certain brain chemicals. Dexmethylphenidate (a stimulant medicine) and isoliquiritigenin (a plant compound) are not peptides but are also mentioned as mood- or focus-affecting substances. “Nootropic” just means something that improves thinking or memory in some way, while “euphoriant” means something that produces strong positive feelings. What does the actual evidence show? It varies a lot by substance. For well-studied stimulants like dexmethylphenidate, there is solid evidence they can improve attention and certain cognitive tasks in the short term, but they can also cause dependence and other side effects. For Semax and Selank, the human evidence is thin and mostly from small studies or clinical reports; some research suggests modest effects on anxiety or attention, but these findings aren’t widely replicated in large, rigorous trials. DLPA and plant compounds have limited and inconsistent data. Crucially, much of the idea that “euphoria equals nootropic” comes from two routes: one, biological changes that could directly support brain plasticity or focus (for example, raising BDNF — a protein that helps nerve cells grow); and two, mood improvement that indirectly frees someone from depression or anxiety, which in turn improves their ability to concentrate. Both routes are plausible, but the strength and reliability of the effects depend on the specific substance and the quality of the studies. Why does this matter for an everyday person? If you struggle with low mood or anxiety, a substance that reliably improves your mood can indeed lead to better thinking, because it removes emotional barriers to focus and motivation. That makes the indirect route clinically useful. On the other hand, if someone without mood problems takes a euphoric agent hoping to boost cognition, the gains might be small, short-lived, or offset by side effects. People interested in cognitive enhancers should pay attention to the evidence for each compound, and consider whether their goal is treating mood, improving a specific cognitive skill, or general performance. There are important caveats and risks. Euphoria-producing drugs can be addictive, can disrupt sleep, and can have cardiovascular or psychiatric side effects. Many peptides like Semax and Selank aren’t approved as nootropics in most countries; their regulation and purity can vary. Long-term effects are often unknown. Also, some substances might help in the short term but harm cognitive health over time if misused. Always be cautious about mixing drugs, and consult a medical professional before trying something new, especially if you have mental health issues or take other medications. Bottom line: Euphoria can sometimes produce real cognitive benefits, mostly by lifting mood or temporarily sharpening attention, but whether a specific euphoric compound is a true, safe nootropic depends on the substance and the quality of evidence — for many of the compounds mentioned, that evidence is limited.
Source: r/Nootropics